Himisha Beltran

2010–2026 年に発表

175
論文数
39,795
被引用数
88
h 指数
159
i10 指数

被引用数

Himisha Beltran の年別被引用数1999 年: 被引用 2 件2003 年: 被引用 1 件2004 年: 被引用 2 件2005 年: 被引用 1 件2006 年: 被引用 2 件2009 年: 被引用 3 件2010 年: 被引用 2 件2011 年: 被引用 7 件2012 年: 被引用 20 件2013 年: 被引用 67 件2014 年: 被引用 193 件2015 年: 被引用 260 件2016 年: 被引用 436 件2017 年: 被引用 565 件2018 年: 被引用 802 件2019 年: 被引用 1,903 件2020 年: 被引用 2,341 件2021 年: 被引用 2,696 件2022 年: 被引用 2,084 件2023 年: 被引用 1,574 件2024 年: 被引用 2,592 件2025 年: 被引用 1,334 件2026 年: 被引用 26 件2000〜2002 年は被引用が無いため表示していません2007〜2008 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,855 件、この内訳の 28.5%中国: 引用元論文 1,950 件、この内訳の 11.4%イギリス: 引用元論文 1,106 件、この内訳の 6.5%イタリア: 引用元論文 811 件、この内訳の 4.7%カナダ: 引用元論文 799 件、この内訳の 4.7%ドイツ: 引用元論文 713 件、この内訳の 4.2%フランス: 引用元論文 547 件、この内訳の 3.2%オーストラリア: 引用元論文 541 件、この内訳の 3.2%スペイン: 引用元論文 474 件、この内訳の 2.8%スイス: 引用元論文 457 件、この内訳の 2.7%日本: 引用元論文 457 件、この内訳の 2.7%オランダ: 引用元論文 436 件、この内訳の 2.5%
0%28.5%その他 22.9%

分野

  • Medicine58%
  • Biochemistry, Genetics and Molecular Biology36.3%
  • Engineering1.8%
  • Immunology and Microbiology1.6%
  • Computer Science0.6%
  • Neuroscience0.3%
  • その他1.4%

トピック

  • Prostate Cancer Treatment and Research11.1%
  • Cancer Genomics and Diagnostics6%
  • Prostate Cancer Diagnosis and Treatment4.6%
  • Cancer Cells and Metastasis3.9%
  • Cancer Immunotherapy and Biomarkers2.1%
  • Epigenetics and DNA Methylation2.1%
  • その他70.2%

共著者

全論文

検索で開く
  1. Integrative Clinical Genomics of Advanced Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Victor E. Reuter, Anuradha Gopalan, Jianjiong Gao, Massimo Loda, Rosina T. Lis, Michaela Bowden, Stephen Balk, Glenn C. Gaviola, Carrie Sougnez, Manaswi Gupta, Evan Y. Yu, Elahe A. Mostaghel, Heather H. Cheng, Hyojeong Mulcahy, Lawrence D. True, Stephen R. Plymate, Heidi Dvinge, Roberta Ferraldeschi, Penny Flohr, Susana Miranda, Zafeiris Zafeiriou, Nina Tunariu, Joaquı́n Mateo, Raquel Pérez-López, Francesca Demichelis, Brian D. Robinson, Marc Schiffman, David M. Nanus, Scott T. Tagawa, Alexandros Sigaras, Kenneth Eng, Olivier Elemento, Andrea Sboner, Elisabeth I. Heath, Howard I. Scher, Kenneth J. Pienta, Philip W. Kantoff, Johann S. de Bono, Mark A. Rubin, Peter S. Nelson, Levi A. Garraway, Charles L. Sawyers, Arul M. Chinnaiyan - Cell 2015 被引用: 3,701

  2. Genomic correlates of clinical outcome in advanced prostate cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Bruce Montgomery, Himisha Beltran, Elisabeth I. Heath, Howard I. Scher, Philip W. Kantoff, Mary‐Ellen Taplin, Nikolaus Schultz, Johann S. de Bono, Francesca Demichelis, Peter S. Nelson, Mark A. Rubin, Arul M. Chinnaiyan, Charles L. Sawyers - National Academy of Sciences, Proceedings of the National Academy of Sciences 2019 被引用: 1,408

  3. Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer

    著者: , , , , , , , , , , , , , , , , , , - Nature Medicine 2016 被引用: 1,729

  4. Organoid Cultures Derived from Patients with Advanced Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen B. Solomon, James A. Eastham, Ping Chi, Brett S. Carver, Mark A. Rubin, Howard I. Scher, Hans Clevers, Charles L. Sawyers, Yu Chen - Cell 2014 被引用: 1,588

  5. SOX2 promotes lineage plasticity and antiandrogen resistance in TP53 - and RB1 -deficient prostate cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Science 2017 被引用: 1,076

  6. Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cyrus V. Hedvat, Michael F. Berger, Lajos Pusztai, Matthias Lechner, Chris Boshoff, Mirna Jarosz, Christine Vietz, Alex Parker, Vincent A. Miller, Jeffrey S. Ross, John A. Curran, Maureen Cronin, Philip J. Stephens, Doron Lipson, Roman Yelensky - Nature Biotechnology 2013 被引用: 2,191

  7. Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eric J. Small - Journal of Clinical Oncology 2018 被引用: 812

  8. Inherited DNA-Repair Gene Mutations in Men with Metastatic Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Liying Zhang, Ahmet Zehir, Joseph Vijai, Howard I. Scher, Charles L. Sawyers, Nikolaus Schultz, Philip W. Kantoff, David B. Solit, Mark E. Robson, Eliezer M. Van Allen, Kenneth Offit, Johann S. de Bono, Peter S. Nelson - New England Journal of Medicine 2016 被引用: 1,663

  9. Suppression of insulin feedback enhances the efficacy of PI3K inhibitors

    著者: , , , , , , , , , , , , , , , , , - Nature 2018 被引用: 733

  10. Prostate cancer

    著者: , , , , , - The Lancet 2021 被引用: 561

  11. Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yu Chen, Ekta Khurana - Science 2022 被引用: 270

  12. The long tail of oncogenic drivers in prostate cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Wassim Abida, Barry S. Taylor, Howard I. Scher, Peter S. Nelson, Johann S. de Bono, Mark A. Rubin, Charles L. Sawyers, Arul M. Chinnaiyan, Nikolaus Schultz, Eliezer M. Van Allen - Nature Genetics 2018 被引用: 884

  13. Molecular Characterization of Neuroendocrine Prostate Cancer and Identification of New Drug Targets

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2011 被引用: 1,020

  14. Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Discovery 2017 被引用: 951

  15. Punctuated Evolution of Prostate Cancer Genomes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Michelle Cipicchio, Kristin Ardlie, Philip W. Kantoff, Michael F. Berger, Stacey Gabriel, Todd R. Golub, Matthew Meyerson, Eric S. Lander, Olivier Elemento, Gad Getz, Francesca Demichelis, Mark A. Rubin, Levi A. Garraway - Cell 2013 被引用: 1,371

  16. The Role of Lineage Plasticity in Prostate Cancer Therapy Resistance

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William L. Dahut, Peter S. Nelson - Clinical Cancer Research 2019 被引用: 394

  17. N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , , , - Cancer Cell 2016 被引用: 565

  18. The Master Neural Transcription Factor BRN2 Is an Androgen Receptor–Suppressed Driver of Neuroendocrine Differentiation in Prostate Cancer

    著者: , , , , , , , , , , , , , , , , , , - Cancer Discovery 2016 被引用: 444

  19. Clinical and Biological Features of Neuroendocrine Prostate Cancer

    著者: , - Current Oncology Reports 2021 被引用: 309

  20. Management of patients with advanced prostate cancer—metastatic and/or castration-resistant prostate cancer: Report of the Advanced Prostate Cancer Consensus Conference (APCCC) 2022

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Noel W. Clarke, Gedske Daugaard, Maria De Santis, Ignacio Durán, Ross Eeles, Eleni Efstathiou, Jason A. Efstathiou, Onyeanunam Ngozi Ekeke, Christopher P. Evans, Stefano Fanti, Felix Y. Feng, Valérie Fonteyne, Nicola Fossati, Mark Frydenberg, Dan George, Martin Gleave, Gwénaëlle Gravis, Susan Halabi, Daniel Heinrich, Ken Herrmann, Celestia Higano, Michael S. Hofman, Lisa G. Horvath, Maha Hussain, Barbara Alicja Jereczek‐Fossa, Robert J. Jones, Ravindran Kanesvaran, Pirkko‐Liisa Kellokumpu‐Lehtinen, Raja B. Khauli, Laurence Klotz, Gero Kramer, Raja Leibowitz, Christopher Logothetis, Brandon A. Mahal, Fernando Cotait Maluf, Joaquı́n Mateo, David Matheson, Niven Mehra, Axel S. Merseburger, Amee Morgans, Michael J. Morris, Hind M’rabti, Deborah Mukherji, Declan G. Murphy, Vedang Murthy, Paul L. Nguyen, William Oh, Piet Ost, Joe M. O’Sullivan, Anwar R. Padhani, Carmel Pezaro, Darren M.C. Poon, Colin C. Pritchard, Danny Rabah, Dana E. Rathkopf, Robert E. Reiter, Mark A. Rubin, Charles J. Ryan, Fred Saad, Juan Pablo Sade, Oliver Sartor, Howard I. Scher, Nima Sharifi, Iwona Skoneczna, Howard R. Soule, Daniel E. Spratt, Sandy Srinivas, Cora N. Sternberg, Thomas Steuber, Hiroyoshi Suzuki ほか 18 名 - European Journal of Cancer 2023 被引用: 157

  21. Cellular plasticity and the neuroendocrine phenotype in prostate cancer

    著者: , , - Nature Reviews Urology 2018 被引用: 437

  22. Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Science Translational Medicine 2019 被引用: 209

  23. Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nicholas J. Dyson, Benjamin J. Drapkin, X. Shirley Liu, Matthew L. Freedman, Michael C. Haffner, Eva Corey, Myles Brown, Henry W. Long - Nature Communications 2021 被引用: 161

  24. Patient derived organoids to model rare prostate cancer phenotypes

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Francesca Demichelis, Mark A. Rubin, Himisha Beltran - Nature Communications 2018 被引用: 356